Series C - Regentis Biomaterials
Investment Firm
Overview
Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.
Announced Date
May 14, 2012
Funding Type
Series C
Highlights
Location
Asia
Social
Investor Lead
N/A
Participant Investors
3
Round Details and Background
Regentis Biomaterials raised $10000000 on 2012-05-14 in Series C
Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Sep 01, 2004 |  Seed Round - Regentis Biomaterials | - | undefined | |
| Aug 21, 2007 | Series B - Regentis Biomaterials | 2 | - | 7.5M |
| Feb 07, 2016 | Series D - Regentis Biomaterials | 5 | - | 15.0M |
| May 14, 2012 | Series C - Regentis Biomaterials | 3 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.